Cite
HARVARD Citation
Papagiannakopoulos, T. (2022). Targeting KEAP1-Mutant NSCLC With Broad-Acting Glutamine Antagonist. Oncology times. 44 (13), pp. 1, 12-12. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Papagiannakopoulos, T. (2022). Targeting KEAP1-Mutant NSCLC With Broad-Acting Glutamine Antagonist. Oncology times. 44 (13), pp. 1, 12-12. [Online].